1.43. Analysis.
Comparison 1 Cholinesterase inhibitor (optimum dose) vs placebo, Outcome 43 Number who suffered at least one adverse event of peripheral oedema before end of treatment at 6 monthsorlater.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.